[HTML][HTML] Clinical characteristics of Pneumocystis pneumonia in non-HIV patients and prognostic factors including microbiological genotypes

…, Y Shindo, Y Iinuma, M Yamamoto, M Shirano… - BMC infectious …, 2011 - Springer
Background The number of patients with non-HIV Pneumocystis pneumonia (PCP) is
increasing with widespread immunosuppressive treatment. We investigated the clinical …

[HTML][HTML] Close cooperation between infectious disease physicians and attending physicians can result in better management and outcome for patients with …

…, Y Iinuma, T Saito, Y Matsumura, M Shirano… - Clinical microbiology …, 2010 - Elsevier
Staphylococcus aureus bacteraemia (SAB) is a serious infection that demands prompt clinical
attention for good outcome. To assess the impact of intervention by infectious diseases …

Accidental exposures to blood and body fluid in the operation room and the issue of underreporting

…, Y Iinuma, J Igawa, Y Matsumura, M Shirano… - American Journal of …, 2009 - Elsevier
A retrospective review of all exposure injuries affecting members of the operative care line
at a single university hospital between January 2000 and December 2007 was performed. A …

The high molecular mass rhoptry protein, RhopH1, is encoded by members of the clag multigene family in Plasmodium falciparum and Plasmodium yoelii

…, T Tsuboi, IT Ling, S Howell, M Shirano… - Molecular and …, 2001 - Elsevier
Malarial merozoite rhoptries contain a high molecular mass protein complex called RhopH.
RhopH is composed of three polypeptides, RhopH1, RhopH2, and RhopH3, encoded by …

[HTML][HTML] A randomised trial of anti-GM-CSF otilimab in severe COVID-19 pneumonia (OSCAR)

…, LE Schwab, Z Shahid, M Shirano… - European …, 2023 - Eur Respiratory Soc
Background Granulocyte–macrophage colony-stimulating factor (GM-CSF) and dysregulated
myeloid cell responses are implicated in the pathophysiology and severity of COVID-19. …

[HTML][HTML] Surgical site infection due to Mycobacterium peregrinum: a case report and literature review

…, M Sonobe, T Bando, T Saito, M Shirano… - International Journal of …, 2009 - Elsevier
OBJECTIVES: Mycobacterium peregrinum is a species included in the Mycobacterium
fortuitum complex, a member of the group of rapidly growing non-tuberculous mycobacteria (RGM)…

A randomized trial of otilimab in severe COVID-19 pneumonia (OSCAR)

…, L Schifano, L Schwab, Z Shahid, M Shirano… - medRxiv, 2021 - medrxiv.org
BACKGROUND Increasing age is a risk factor for COVID-19 severity and mortality;
emerging science implicates GM-CSF and dysregulated myeloid cell responses in the …

[PDF][PDF] COVID-19 relapse associated with SARS-CoV-2 evasion from CD4+ T-cell recognition in an agammaglobulinemia patient

…, Y Ichida, K Amo, T Goto, J Hara, M Shirano… - Iscience, 2023 - cell.com
A 25-year-old patient with a primary immunodeficiency lacking immunoglobulin production
experienced a relapse after a 239-day period of persistent severe acute respiratory syndrome …

[HTML][HTML] Dengue virus type 1 infection in traveler returning from Tanzania to Japan, 2019

…, K Egawa, Y Hirai, A Kaida, M Shirano… - Emerging infectious …, 2019 - ncbi.nlm.nih.gov
The largest outbreak of dengue fever in Tanzania is ongoing. Dengue virus type 1 was
diagnosed in a traveler who returned from Tanzania to Japan. In phylogenetic analysis, the …

Comparison between procalcitonin and C-reactive protein in predicting bacteremias and confounding factors: a case-control study

H Nishikawa, M Shirano, Y Kasamatsu… - Clinical Chemistry and …, 2017 - degruyter.com
Background: The detection of infectious bacteria in blood culture samples is important for
diagnosis and treatment, but this requires 1–2 days at least, and is not adequate as a rapid test…